Electrophoresis Market - Global Forecast 2025-2032

The electrophoresis market is experiencing dynamic transformation, influenced by advances in automation, digital integration, and evolving end-user demands. Amid global supply chain shifts and regulatory changes, senior leaders are seeking clarity to inform procurement, strategy, and investment decisions in this rapidly evolving field.

Market Snapshot: Electrophoresis Market Size and Growth

The Electrophoresis Market grew from USD 3.47 billion in 2024 to USD 3.69 billion in 2025 and is projected to reach USD 5.69 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.37%.

Electrophoresis Market: Scope & Segmentation

This report delivers comprehensive insights and segmentation, focusing on product types, applications, end-user ecosystems, regional market nuances, technology trends, and provider activities.

• Product Categories: Consumables (buffers, gels, kits, reagents), Equipment (agarose gel systems, capillary arrays, polyacrylamide gel instruments, pulsed field platforms), Services, Software
• Application Domains: Clinical diagnostics, forensics, pharmaceutical quality assessment, research and biomarker discovery
• End User Segments: Academic & research institutes, forensic laboratories, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies
• Geographic Segmentation: Americas (including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (UK, Germany, France, and more; South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
• Key Players Analyzed: Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Danaher Corporation, PerkinElmer, Inc., Waters Corporation, GE HealthCare Technologies Inc., Shimadzu Corporation, Bio-Techne Corporation

Key Takeaways for Senior Decision-Makers

• Modern electrophoresis platforms underpin critical quality control, diagnostics, and research workflows, supporting decision-making across life sciences and healthcare.
• Technological advancements—including microfluidics, automation, and intelligent software—are streamlining laboratory processes and enabling new analytic capabilities at scale.
• Integration with complementary technologies, such as mass spectrometry and next-generation sequencing, provides end-to-end solutions for molecular characterization and data-driven insight.
• Market segmentation highlights varied needs, from modular, flexible research systems to validated consumables essential for regulated forensics and diagnostic labs.
• Regional trends reflect distinct priorities: North America and Europe demand innovation and compliance, Asia-Pacific drives high-volume adoption, and local sourcing is becoming more important due to evolving trade policies.
• Strategic partnerships, product diversification, and robust aftermarket services are central to maintaining provider competitiveness and customer satisfaction.

Tariff Impact and Supply Chain Adaptation

Recent U.S. tariffs on imported consumables and equipment have shifted procurement strategies, prompting laboratories to diversify suppliers, consider bulk purchasing, and adopt locally produced alternatives. Equipment vendors are increasingly pursuing nearshoring, collaborating regionally, and rethinking design to bypass cross-border duties. These adaptations encourage domestic innovation and foster closer industry-user alignment while promoting supply chain resilience.

Methodology & Data Sources

The findings in this electrophoresis research are anchored in a multi-layered methodology combining expert interviews, procurement and service data analysis, and review of peer-reviewed publications and patents. An advisory panel contributed to validating trends and strategic recommendations, ensuring actionable, reliable insights for B2B stakeholders.

Why This Report Matters

• Equips executives with segmented, actionable insights to inform strategy and operational resilience in the face of regulatory and technological disruption.
• Enables benchmarking of regional and provider-specific developments, supporting competitive analysis and procurement decision-making.
• Provides a detailed roadmap for investment in automation, sustainability, and emerging digital solutions critical to future-proofing electrophoresis operations.

Conclusion

This report presents senior stakeholders with the strategic clarity needed to evaluate market opportunities and risks in the electrophoresis sector. Through deep analysis of technology, segmentation, and regional dynamics, it supports informed decision-making for business growth and operational excellence.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.